An interventional study of Debriefing of high-fidelity sepsis simulation scenarios and Placebo: Debriefing of high-fidelity non-sepsis simulation scenarios in Medical Knowledge and Clinical Performance, sponsored by NYU Langone Health. Terminated at 1 site in United States. Open to participants aged 20 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-12-08.
Sponsored by NYU Langone Health · Not applicable and Interventional
The primary objective of the proposed study will be to determine if a multi-modality teaching curriculum utilizing high-fidelity simulation and didactic lecture will result in sustained improvement by internal medicine residents in written knowledge and clinical performance when compared to residents receiving a curriculum utilizing only didactic lecture. The investigators hypothesis is that the addition of high-fidelity simulation to a traditional didactic lecture curriculum will result in sustained and superior written knowledge and practical performance when compared to a group receiving only didactic lecture on the same topic. Specifically, the investigators will be assessing internal medicine resident knowledge and performance in the area of sepsis in the hospitalized patient, and will shape the investigators teaching curriculum around this focus.
This is a randomized prospective single-blinded pilot study. Residents from the internal medicine residency program will be assigned a unique number to de-identify them, and then randomized, stratified by post-graduate year (PGY) level, by random number generator to intervention and control groups. Only de-identified information will be used in subsequent analysis, and no individual results will be used. Residents will not know to which group they have been randomized.
Both the intervention and control groups will take a pre-course survey assessing their level of training, area of specialty/interest, and level of confidence in the recognition and management of sepsis.
Both the intervention and control groups will then be put through 2-4 simulated scenarios using high-fidelity simulation. In the intervention group, these scenarios will be sepsis syndrome scenarios. In the control group, non-sepsis scenarios will be administered.
Immediately following the scenarios, a written knowledge quiz focusing on recognition and management of sepsis will be administered to subjects in both groups.
Following the quiz, there will be a debrief session for subjects in both groups of the simulation scenarios, pointing out what was done correctly and what was not.
There will then be a brief didactic teaching session focusing on recognition and management of sepsis administered to subjects in both groups.
2-4 months later, subjects in both groups will be brought back to the simulation lab and tested on a new identical set of simulated sepsis scenarios. This will be videotaped and scored by an impartial volunteer who will score performance according to a check-list of critical actions. Following the simulated scenarios, the written quiz administered at the first visit will be given again. Subjects in both groups will then get debriefed on their performance.
Data can then be compared between the control and intervention group in terms of written and practical performance. Other potential analyses include before and after performance in the intervention group, comparison between the intervention and control groups, as well as subanalysis by PGY level. Student's paired and unpaired t-test will be the model for statistical analysis, and the investigators will utilize a statistician for data analysis.
In developing and implementing a multi-modality sepsis teaching curriculum, and demonstrating its superiority to a didactic-only curriculum, the investigators hope to justify the permanent implementation of a multi-modality teaching module to educate residents (and other healthcare personnel) which will lead to improved recognition and management of sepsis and improved patient outcomes.
1,899 studies on the registry are indexed under Sepsis; 462 are open to participants now.
This study's enrollment of 40 is below the median of 105 across 896 interventional studies indexed under Sepsis.
Browse Sepsis studies →NYU Langone Health is the lead sponsor of 1,391 studies on the registry; 254 are open to participants now.
Of its 227 completed or terminated interventional studies of FDA-regulated products, 191 (84%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
First visit: * Subjects will fill out a self-assessment focusing on perceptions of their knowledge and ability in the recognition and management of sepsis in hospitalized patient * Subjects will be specifically exposed to high-fidelity simulated sepsis scenarios and be debriefed on their performance in these scenarios (intervention) * Subjects will take a written test focusing on early recognition and management of sepsis * Subjects will receive a didactic teaching session focusing on recognition and management of early sepsis in the hospitalized patient In the second visit: * Subjects will be exposed to a number of high-fidelity simulated sepsis scenarios and be scored on their performance in management of these scenarios * Subjects will take a written test of knowledge focusing on early recognition and management of sepsis * Subjects will then be debriefed specifically on their performance in the simulation scenarios
Other: Debriefing of high-fidelity sepsis simulation scenarios
First visit: * Subjects will fill out a self-assessment survey of their perceptions of their knowledge and ability in the recognition and management of sepsis in the hospitalized patient * Subjects will be exposed to high-fidelity simulation scenarios (non-sepsis) and be debriefed in terms of their performance in these scenarios * Subjects will take a written test of knowledge focusing on early recognition and management of sepsis * Subjects will receive a didactic teaching session focusing on recognition and management of early sepsis in the hospitalized patient In the second visit: * Subjects will be exposed to a number of high-fidelity simulated sepsis scenarios and be scored on their performance in management of the scenarios * Subjects will take a written test of knowledge focusing on early recognition and management of sepsis * Subjects will then be debriefed specifically on their performance in the simulation scenarios
Other: Placebo: Debriefing of high-fidelity non-sepsis simulation scenarios
Educational intervention
Also known as: Education, High-fidelity simulation, Debriefing
Performance on a written assessment of the recognition and management of early sepsis in the hospitalized patient.
Written test
Time frame: 2-4 months after intervention
Performance on a practical assessment of the recognition and management of early sepsis in the hospitalized patient.
Graded performance in simulated sepsis scenario utilizing high-fidelity simulation
Time frame: 2-4 months after intervention
Self-assessment of knowledge and ability in the recognition and management of early sepsis in the hospitalized patient.
Written self-assessment survey
Time frame: 2-4 months after intervention
This study is terminated, as verified in Dec 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
NYU Langone Health